Latest filing published 15 Feb 2022 for Praxis Precision Medicines, Inc., €34k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Bernard Ravina: trading record in brief
Bernard Ravina, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Voyager Therapeutics, Inc. and Praxis Precision Medicines, Inc. The record holds 14 filings, for trades running from 20 July 2017 to 12 February 2022.
No open-market purchase appears, only 10 sales worth €712k. Outside the open market, there are 3 share grants and 1 option exercise.
The latest filing, published on 15 February 2022, reports a share grant of €34k in Praxis Precision Medicines, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bernard Ravina
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,057 shares@ US$12.85100.0% of flowCommon StockSEC:0001689548-22-000007:0
- 22,000 shares0Common StockSEC:0001104659-22-003162:0
2 of 2 declarations
